Search

everythinglearnresearchcommunity

for

Search:↓

A woman in Sri Lanka was diagnosed with lupus after presenting with protein loss from the gut and other symptoms.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

Long eyelashes in a patient were an unusual sign of systemic lupus erythematosus.

Early identification of lupus through skin signs and blood tests is crucial in India.

A child with a rare scalp condition regrew hair after treatment.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Lupus can cause hair loss and nail changes, with treatments available for both.

Lupus patients' body image issues significantly affect their mental health and need more support.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

CD2 might be a new treatment target for patchy alopecia areata.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

A woman with lupus had rare severe symptoms but improved with treatment.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.